| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.35 | 7e-17 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.31 | 2e-14 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.29 | 4e-13 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.42 | 8e-12 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.25 | 4e-09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.3 | 1e-06 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.28 | 5e-06 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-05 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 1e-05 |